Market Tracker

10/23 3:41am ET

Novelion Therapeutics Inc (NASDAQ:NVLN)

6.55
Delayed Data
As of Oct 20
 -0.02 / -0.30%
Today’s Change
6.41
Today|||52-Week Range
13.80
-22.21%
Year-to-Date
No recent news for Novelion Therapeutics Inc.

Today’s Trading

Previous close6.57
Today’s open6.59
Day’s range6.47 - 6.63
Volume28,900
Average volume (3 months)96,806
Market cap$122.2M
Dividend yield--
Data as of 3:59pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)-113.18%
Earnings growth (this year)+78.73%
Earnings growth (next 5 years)+74.60%
Revenue growth (last year)--
P/E ratioNM
Price/Sales7.00
Price/Book0.89

Competitors

 Today’s
change
Today’s
% change
CDTXCidara Therapeutics ...+0.60+8.70%
CTSOCytosorbents Corp+0.05+0.83%
CDXCChromadex Corp+0.06+1.44%
NATRNatures Sunshine Pro...-0.10-0.99%
Data as of 3:59pm ET, 10/20/2017

Financials

Next reporting dateOctober 31, 2017
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$13.6M
Annual profit (last year)-$52.9M
Net profit margin-389.49%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mary J. Szela
Chief Financial &
Administrative Officer
Gregory D. Perry
Corporate headquarters
Vancouver, British Columbia

Forecasts